New nine and ten coordinated complexes of lanthanides with bidentate 2-pyrazinecarboxylate containing hydrazinium cation

The new hydrazinium lanthanide metal complexes of 2-pyrazinecarboxylic acid of the formulae (N₂H₅)₂[Ln(pyzCOO)₅] · 2H₂O (1), where Ln = La or Ce and (N₂H₅)₃[Ln(pyzCOO)₄(H₂O)] · 2NO₃ (2), where Ln = Pr, Nd, Sm or Dy have been synthesized by the addition of an aqueous solution of corresponding metal nitrate hydrates to an aqueous mixture of carboxylic acid and hydrazine hydrate in an appropriate ratios. The structure of (N₂H₅)₂[La(pyzCOO)₅] · 2H₂O (1a) and (N₂H₅)₃[Nd(pyzCOO)₄(H₂O)] · 2NO₃ (2a) have been determined from single crystal X-ray analysis. Coordination numbers from six to twelve have been established in lanthanide compounds but ten coordination appears rarely. This work reports the first ten coordinated hydrazinium lanthanide complexes with carboxylate anions. The structure contains lanthanum ions joined by 2-pyrazinecarboxylate groups forming two-dimensional sheets parallel to (0 0 1) plane. 2a is monomeric in nature and the structure comprises of N₂H₅⁺ cations, [Nd(pyzCOO)₄(H₂O)]⁻ and anions. The neodymium is nine coordinated with four pyzCOO lignads, bidentate (N,O) to the metal and the lone water molecule completes the coordination sphere and the sheets like pattern in all are interlinked via multiple hydrogen bonds leading to three dimensional structure.     

Liquid chromatography-tandem mass spectrometry validated method for the estimation of indapamide in human whole blood

A highly precise and sensitive method for the estimation of indapamide in human whole blood using high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) is described. The method developed is validated in human whole-blood matrix, with a sensitivity of 0.5 ng/ml as lower limit of quantification. The procedure for the extraction of indapamide and glimepiride as internal standard (IS) involves haemolysis and deprotienation of whole blood using ZnSO(4) followed by liquid-liquid extraction using ethyl acetate. The sample extracts after drying were reconstituted and analysed by LC-MS/MS, equipped with turbo ion spray (TIS) source, operating in the positive ion and selective reaction monitoring (SRM) acquisition mode to quantify indapamide in human whole blood. The mean recovery for indapamide was 82.40 and 93.23% for IS. The total run time was 2.5 min to monitor both indapamide and the IS. The response of the LC-MS/MS method for indapamide was linear over the range of 0.5-80.0 ng/ml with correlation coefficient, r>or=0.9991. The coefficient of variance (% CV) at 0.5 ng/ml was 4.02% and the accuracy was well within the accepted limit of +/-20% at 0.5 ng/ml and +/-15% at all other concentrations in the linear range. This method is fully validated for the accuracy, precision and stability studies and also applied to subject-sample analysis of bioequivalence study for 1.5mg sustained-release (SR) formulations.     

Inferences Concerning a Mean Vector when the Variables are Grouped into Subsets

In experiments involving multivariate measurements biological considerations often indicate a grouping of the variables into subsets such that all the variables in a subset are equally important and the subsets may be arranged in a decreasing order of importance (JENSEN, 1972). This paper deals with a method of analysis appropriate in such cases, to solve multivariate problems such as profile analysis, comparison of two mean vectors, or univariate problems such as analysis of SCHEFFÉ'S mixed effects model with interaction (SCHEFFÉ, 1959; MILLER, 1966), usually treated using HOTELLING'S T². An invariance structure underlying this procedure is examined and used to obtain noncentrality parameters of the power function, and derive some of its properties. The multiple comparisons procedure in MUDHOLKAR and SUBBAIAH (1976) is extended and illustrated in terms of the data from a clinical trial.     

A high-performance liquid chromatographic procedure for the determination of disaturated phosphatidylcholine in human plasma

Plasma disaturated phosphatidylcholine (DSPC) concentration has been implicated as a risk factor for atherosclerosis. However, suitable methods for the estimation of these compounds in plasma are not available. In this paper, a method for the estimation of DSPC using argentation thin-layer chromatography and high-performance liquid chromatography is described. It is quantitative for the measurement of individual and total DSPC species and is not dependent on fatty acid chain length. The method employs hydrolysis of total plasma phosphatidyl choline by phospholipase C, followed by benzoylation of the diacylglycerols. The benzoates are then fractionated on silver nitrate-impregnated silica gel thin-layer chromatography plates, and the disaturated species separated and quantitated by high-performance liquid chromatography. The method is sensitive and reproducible and allows many samples to be done at once. With this method, the amounts of DSPC were found to be significantly higher in a group of normolipidemic diabetic subjects, compared to age-matched controls.     

The Invasive Capacity of HPV Transformed Cells Requires the hDlg-Dependent Enhancement of SGEF/RhoG Activity

A major target of the HPV E6 oncoprotein is the human Discs Large (hDlg) tumour suppressor, although how this interaction contributes to HPV-induced malignancy is still unclear. Using a proteomic approach we show that a strong interacting partner of hDlg is the RhoG-specific guanine nucleotide exchange factor SGEF. The interaction between hDlg1 and SGEF involves both PDZ and SH3 domain recognition, and directly contributes to the regulation of SGEF''s cellular localization and activity. Consistent with this, hDlg is a strong enhancer of RhoG activity, which occurs in an SGEF-dependent manner. We also show that HPV-18 E6 can interact indirectly with SGEF in a manner that is dependent upon the presence of hDlg and PDZ binding capacity. In HPV transformed cells, E6 maintains a high level of RhoG activity, and this is dependent upon the presence of hDlg and SGEF, which are found in complex with E6. Furthermore, we show that E6, hDlg and SGEF each directly contributes to the invasive capacity of HPV-16 and HPV-18 transformed tumour cells. These studies demonstrate that hDlg has a distinct oncogenic function in the context of HPV induced malignancy, one of the outcomes of which is increased RhoG activity and increased invasive capacity.     

MANOVA multiple comparisons using the generalized step-down procedure

If the variables in MANOVA problem can be arranged according to the order of their importance, then J. ROY'S (1958) step-down procedure may be more appropriate than the conventional invariant inference techniques. However, it may often be possible only to identify subsets such that variables within subsets are equally important and subsets are of unequal importance. In experimental situations, it is common to have a set of variables of primary interest and another of “addon” variables. The step-down reasoning is extended to such cases and a set of simultaneous confidence bounds based upon the procedure which uses the largest root criterion at each stage are derived. The confidence bounds are on all linear functions of means only that do not involve nuisance parameters, and are therefore suitable for studying the configuration of means. This method yields shorter intervals for contrasts among the means of the variables of primary interest compared with the conventional intervals based upon the largest root. The method is illustrated using BARNARD'S data (1935) on skull characters.     

Glucocorticoid-related impairment in the metabolism of low density lipoprotein by human fibroblasts

The metabolism of radiolabelled 125I-low density lipoprotein (LDL) was studied in cultured human dermal fibroblasts to investigate potential mechanisms contributing to the accelerated development of cardiovascular disease in patients treated chronically with corticosteroids. Fibroblasts exposed for 48 hours to pooled lipoprotein-poor (d greater than 1.25 gm/ml) serum from glucocorticoid-treated patients showed an increased capacity to bind LDL (p less than .001) compared to cells incubated under identical conditions with pooled serum from controls. In addition, a significantly (p less than .001) reduced amount of soluble radioactive material appeared in the media indicating that exposure of fibroblasts to corticosteroid serum also impaired their capacity to degrade LDL. If this tendency of cultured cells to accumulate cholesterol-rich lipoprotein when exposed to constituents of serum from these patients is present in patients receiving long-term treatment with glucocorticoids, it might influence arterial lipid accumulation and accelerate their developing cardiovascular disease.     

Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters.

The positional specificity of purified human lecithin-cholesterol acyltransferase (LCAT) was studied by analyzing the labeled cholesteryl ester (CE) species formed in the presence of proteoliposome substrates containing mixed chain phosphatidylcholine (PC) species, labeled cholesterol and apoprotein A-I. Whereas over 90% of the acyl groups used for CE synthesis were derived from the sn-2 position of most of the naturally occurring PC substrates, about 75% of the CE species formed in the presence of sn-1-myristoyl 2-arachidonoyl PC, sn-1-palmitoyl-2-arachidonoyl (PAPC) and sn-1-palmitoyl 2-docosahexaenoyl PC were derived from the sn-1-position. On the other hand, rat LCAT utilized mostly sn-2-acyl group from either PAPC or from sn-1-palmitoyl 2-linoleoyl PC. The positional specificity of the human enzyme was not affected by the alteration in the matrix fluidity, type of the apoprotein activator used, or by the free cholesterol/PC ratio in the substrate. These results show that the positional specificity of human plasma LCAT is altered in the presence of sn-2-arachidonoyl PC, or sn-2-docosahexaenoyl PC, probably due to steric restrictions at the active site, and this may account for the formation of disproportionately high concentrations of saturated CE, and low concentrations of long-chain polyunsaturated CE in human plasma, relative to the composition of sn-2-acyl groups in plasma PC.     

Interaction of the components of the prothrombinase complex

The interaction of components of the prothrombinase complex, i.e. bovine Factor X or Factor Xa. bovine Factor V or Factor Va, phospholipid, and Ca²⁺, in various combinations was studied primary by a gel filtration technique. In experiments, in which phospholipids ranging from those isolated from naturally occurring sources to those long chain (18 : 1) as well as short chain 6 : o and 7 : 0 fatty acids prepared by chemical and enzymatic synthesis were used, it was evident that a net negative surface charge on the lipid dispersions was one of the important requirements for interaction. Though the short chain fatty acid phospholipids interacted with the proteins of the prothrombinase complex, there was invariably a diminution in the activity of the enxyme complex. It was established that Factor V or Va did not bind Ca²⁺ and that the binding of either of these factors with phospholipids (with a net negative charge) was not dependent on Ca²⁺. However, the interaction of Factor X or Factor Xa with phospholipids with a negative charge required Ca²⁺. It was shown that Factor X could bind to the same type of lipid surface as that notes for Factor Xa. Of interest was the apparent difference in the phospholipid binding characteristics of the two variant forms of bovine plasma Factor X, i.e. X₁ and X₂, which might in part explain the differences in their specific activities. Of importance was the lack of demonstrable complex formation between Factors II, X and V in the absence of phospholipids and/or in the presence or absence of Ca²⁺. The significance of these results as they might apply to the configuration of the prothrombinase complex and its interaction with prothrombin plus the usefulness of the short chain fatty phospholipid in exploring these lipid-protein interactions are discussed.